Compare UTL & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UTL | AHG |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Power Generation | Business Services |
| Sector | Utilities | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.9M | 1.1B |
| IPO Year | 1995 | 2017 |
| Metric | UTL | AHG |
|---|---|---|
| Price | $51.00 | $1.20 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $56.50 | N/A |
| AVG Volume (30 Days) | ★ 103.6K | 5.8K |
| Earning Date | 05-04-2026 | 08-14-2025 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | ★ 1.37 | N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | ★ $536,000,000.00 | N/A |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $4.22 | N/A |
| P/E Ratio | $27.60 | ★ N/A |
| Revenue Growth | ★ 8.33 | N/A |
| 52 Week Low | $45.11 | $1.08 |
| 52 Week High | $55.08 | $2.50 |
| Indicator | UTL | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 48.73 | 38.58 |
| Support Level | $49.18 | $1.28 |
| Resistance Level | $51.06 | $1.67 |
| Average True Range (ATR) | 1.44 | 0.13 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 50.57 | 48.00 |
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.